Nuzenio

Ligachem

Ligachem news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

LigaChem Gains Sole Control of B7-H4 Cancer Drug With Distinct Tumor-Killing Mechanism - Tech TimesTech Times · Fri, 07 Aug 2026 18:29:26 GMTLigaChem Biosciences Takes Solo Control of ADC Cancer Drug After NextCure's Strategic Pivot - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 06:05:00 GMTLigaChem Bio Gains Sole Development Rights to Co-Developed ADC Drug - Seoul Economic DailySeoul Economic Daily · Fri, 07 Aug 2026 04:55:57 GMTLigachem Biosciences takes sole control of ADC LNCB74, pursues global licensing - CHOSUNBIZ - ChosunbizChosunbiz · Fri, 07 Aug 2026 02:15:00 GMTFrom licensing deals to patients: LigaChem and ABL Bio shift focus to clinical proof - koreabiomed.comkoreabiomed.com · Wed, 05 Aug 2026 07:12:03 GMTLigaChem Biosciences wins third US ADC trial nod with ExoThera’s IKS04 - CHOSUNBIZ - ChosunbizChosunbiz · Fri, 31 Jul 2026 07:00:00 GMTLigaChem Bio's ADC Platform Drug 'IKS04' Wins U.S. IND Approval - Seoul Economic DailySeoul Economic Daily · Fri, 31 Jul 2026 00:45:02 GMT

Timeline

Fri, 07 Aug 2026 18:29:26 GMTLigaChem Gains Sole Control of B7-H4 Cancer Drug With Distinct Tumor-Killing Mechanism - Tech Times
Fri, 07 Aug 2026 06:05:00 GMTLigaChem Biosciences Takes Solo Control of ADC Cancer Drug After NextCure's Strategic Pivot - finance.biggo.com
Fri, 07 Aug 2026 04:55:57 GMTLigaChem Bio Gains Sole Development Rights to Co-Developed ADC Drug - Seoul Economic Daily
Fri, 07 Aug 2026 02:15:00 GMTLigachem Biosciences takes sole control of ADC LNCB74, pursues global licensing - CHOSUNBIZ - Chosunbiz
Wed, 05 Aug 2026 07:12:03 GMTFrom licensing deals to patients: LigaChem and ABL Bio shift focus to clinical proof - koreabiomed.com
Fri, 31 Jul 2026 07:00:00 GMTLigaChem Biosciences wins third US ADC trial nod with ExoThera’s IKS04 - CHOSUNBIZ - Chosunbiz

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ligachem.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.